CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Teriparatide (rDNA origin) injection

Last Updated: May 29, 2006
Result type: Reports
Project Number: S0065
Product Line: Common Drug Review

Generic Name: Teriparatide (rDNA origin) injection

Brand Name: Forteo

Manufacturer: Eli Lilly Canada Inc.

Indications: Osteoporosis

Submission Type: Resubmission

Project Status: Withdrawn